Remyelination News and Research

RSS
Remyelination is a term for the re-generation of the nerve's myelin sheath, damaged in many diseases such as multiple sclerosis (MS) and the leukodystrophies. Remyelination is a subject of active medical research.
Mouse model shows how chronic demyelination may cause seizures in MS patients

Mouse model shows how chronic demyelination may cause seizures in MS patients

Researchers identify genetic risk factor for binge eating

Researchers identify genetic risk factor for binge eating

Clinical trial assesses efficacy of experimental treatment in individuals with cervical spinal cord injury

Clinical trial assesses efficacy of experimental treatment in individuals with cervical spinal cord injury

Cell therapy product can accelerate brain remyelination in mice

Cell therapy product can accelerate brain remyelination in mice

Innovations in pre-clinical MRI: an interview with Priv. Doz. Dr. Dominik von Elverfeldt

Innovations in pre-clinical MRI: an interview with Priv. Doz. Dr. Dominik von Elverfeldt

Novoron Bioscience receives NIH grant to study novel therapeutic approach for multiple sclerosis

Novoron Bioscience receives NIH grant to study novel therapeutic approach for multiple sclerosis

Asterias’ Phase 1/2a study evaluates dose escalation of AST-OPC1 for cervical spinal cord injury

Asterias’ Phase 1/2a study evaluates dose escalation of AST-OPC1 for cervical spinal cord injury

Experimental drug shows promise in mice with multiple sclerosis

Experimental drug shows promise in mice with multiple sclerosis

Researchers reveal molecular mechanism that controls remyelination

Researchers reveal molecular mechanism that controls remyelination

Several drugs could lead to new MS treatment options

Several drugs could lead to new MS treatment options

Two existing drugs may potentially become new drug target for multiple sclerosis

Two existing drugs may potentially become new drug target for multiple sclerosis

New longer-term data on Genzyme's relapsing MS treatments to be presented at AAN 2015

New longer-term data on Genzyme's relapsing MS treatments to be presented at AAN 2015

Existing drug could help treat MS, other neurological diseases

Existing drug could help treat MS, other neurological diseases

Ligand indazole chloride improves motor function, study shows

Ligand indazole chloride improves motor function, study shows

Asterias, CIRM sign NGA to begin AST-OPC1 study for complete cervical spinal cord injury

Asterias, CIRM sign NGA to begin AST-OPC1 study for complete cervical spinal cord injury

Cell transplantation treatment may benefit people with spinal cord injury

Cell transplantation treatment may benefit people with spinal cord injury

New MS treatment found safe, tolerable in phase I clinical trials

New MS treatment found safe, tolerable in phase I clinical trials

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Neuregulin 1 effective in promoting peripheral nerve regrowth

Neuregulin 1 effective in promoting peripheral nerve regrowth

Researchers identify protein that promotes growth of brain cells damaged by MS

Researchers identify protein that promotes growth of brain cells damaged by MS